Abstract
Preeclampsia and superimposed preeclampsia usually develop after 20 weeks of gestation. We report a case of a 35-year-old Japanese woman who developed hypertensive disorders of pregnancy (HDP) before 20 weeks of gestation. She presented with hypertension and proteinuria at 9 and 11 weeks of gestation, respectively, and developed nephrotic syndrome at 17 weeks of gestation. She did not have definite hypertension or urinary abnormalities before pregnancy. The patient was serologically positive for the antinuclear antibody. However, the complement levels were normal and anti-phospholipid antibody was not detected. A renal biopsy performed at 18 weeks of gestation showed diffuse endotheliosis and tip lesions of secondary focal segmental glomerulosclerosis but no hypertensive changes of the arterioles. Although electron microscopic examination showed electron-dense deposits in the subendothelial lesions, they were considered nonspecific plasma exudation by mass spectrometry. An abortion was performed at 20 weeks gestation because the patient’s congestive symptoms due to nephrotic syndrome had worsened and marked fetal growth restriction was observed. After delivery, the patient’s symptoms resolved immediately without any additional treatment; however, continuous antihypertensive medication was required. Finally, the patient was diagnosed with HDP based on the renal biopsy findings and her clinical course after delivery. Compared to previous reports, this case describes the earliest onset of HDP. Thus, HDP should be considered as a differential diagnosis in pregnant women with hypertension or proteinuria presenting with symptoms before 20 weeks of gestation.
Similar content being viewed by others
References
Makino S, Takeda J, Takeda S, Watanabe K, Matsubara K, Nakamoto O, Ushijima J, Ohkuchi A, Koide K, Mimura K, Morikawa M, Naruse K, Tanaka K, Nohira T, Metoki H, Kawabata I, Takagi K, Yamasaki M, Ichihara A, Kimura T, Saito S, Seki H. New definition and classification of “hypertensive disorders of pregnancy (HDP). Hypertens Res Pregnancy. 2019;7:1–5.
Hazra S, Waugh J, Bosio P. ‘Pure’ pre-eclampsia before 20 weeks of gestation: a unique entity. BJOG. 2003;110:1034–5.
Imasawa T, Nishiwaki T, Nishimura M, Shikama N, Matsumura R, Nagai M, Soyama A, Koike K, Kitamura H, Joh K. A case of “pure” preeclampsia with nephrotic syndrome before 15 weeks of gestation in a patient whose renal biopsy showed glomerular capillary endotheliosis. Am J Kidney Dis. 2006;48:495–501.
Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol. 2007;18:2281–4.
Maya ID. Hypertension and proteinuria in a 17-year-old at 19weeks’gestation. Am J Kidney Dis. 2008;51:155–9.
Tanaka M, Tsujimoto Y, Goto K, Kumahara K, Onishi S, Iwanari S, Fumihara D, Miki S, Ikeda M, Sato K, Sato H, Hirose M, Takeoka H. Preeclampsia before 20 weeks of gestation: a case report and review of the literature. CEN Case Rep. 2015;4:55–60.
Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management. Am J Gastroenterol. 2017;112:838–46.
Paller MS. Hypertension in pregnancy. J Am Soc Nehorol. 1998;9:314–21.
Pignatelli P, Ettorre E, Menichelli D, Pani A, Violi F, Pastori D. Seronegative antiphospholipid syndrome:refining the value of “non-criteria” antibodies for diagnosis and clinical management. Haematologica. 2020;105:562–72.
Fakhouri F, Roumenina L, Provot F, Sallée M, Caillard S, Couzi L, Essig M, Ribes D, Dragon-Durey MA, Bridoux F, Rondeau E, Frémeaux-Bacchi V. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol. 2010;21:859–67.
Abisror N, Nguyen Y, Marozio L, Valverde EE, Udry S, Pleguezuelo DE, Billoria P, Mayer PK, Urbanski G, Zigon P, Moreuil CD, Hoxha A, Bezanahary H, Carbillion L, Kayem G, Bornes M, Yelnik C, Johanet C, Nicaise RP, Lambert M, Salle V, Latino OJ, Hachulla E, Benedetto C, Bourrienne MC, Benhamou Y, Alijotas RJ, Fain O, Mekinian A. Obstetrical outcome, and treatments in seronegative primary APS: data from European retrospective study. RMD Open. 2020;6:e001340.
Oku K, Atsumi T, Bohgaki M, Amengual O, Kataoka H, Horita T, Yasuda S, Koike T. Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis. 2009;68:1030–5.
Nochy D, Daugas E, Droz D, Beaufils H, Grunfeld JP, Piette JC, Bariety J, Hill G. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999;10:507–18.
Mekinian A, Bourrienne MC, Carbillon L, Benbara A, Noemie A, Chollet MS, Tigaizin A, Montestruc F, Fain O, Nicaise RP. Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Precvalence and treatment efficacy in pregnancies. Semin Arthritis Rheum. 2016;46:232–7.
Japan Society for the Study of HYPERTENSION IN PREGNANCY. Best Practice Guide 2015 for Care and Treatment of Hypertension in Pregnancy. 1st ed. Medical View; 2015
Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol. 1994;171:410–6.
Qin J, Liu X, Sheng X, Wang H, Gao D. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105:73–85.
Sites CK, Wilson D, Barsky M, Bernson D, Bernstein IM, Boulet S, Zhang Y. Embryo cryopreservation and preeclampsia risk. Fertil Steril. 2017;108:784–90.
Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S. Predictive Value of the sFlt-1: PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016;374:13–22.
Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez H, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H, Benzing T. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol. 2016;27:903–13.
Nakashima A, Yamanaka-Tatematsu M, Fujita N, Koizumi K, Shima T, Yoshida T, Nikaido T, Okamoto A, Yoshimori T, Saito S. Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia. Autophagy. 2013;9:303–16.
Seki H. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia. Acta Obstet Gynecol Scand. 2014;93:959–64.
Sani HM, Vahed SZ, Ardalan M. Preeclampsia: a close look at renal dysfunction. Biomed Pharmacother. 2019;109:408–16.
Levine RJ, Maynard SE, Qian C, Lim K, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–83.
Saito S, Sakai M, Sasaki Y, Nakashima A, Shiozaki A. Inadequate tolerance induction may induce preeclampsia. J Reprod Immunol. 2007;76:30–9.
Sasaki Y, Kolarz DD, Suzuki D, Sakai M, Ito M, Shima T, Shiozaki A, Rolinski J, Saito S. Proportion of peripheral blood and decidual CD4+ CD25bright regulatory T cells in pre-eclampsia. Clin Exp Immunol. 2007;149:139–45.
Jennette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall’s pathology of the kidney: hypertensive disorders of pregnancy, vol. 6. Netherlands: Wolters Kluwer; 2007. p. 773–85.
Zhang J, Troendle JF, Levine RJ. Risks of hypertensive disorders in the second pregnancy. Paediatr Perinat Epidemiol. 2001;15:226–31.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hayashi, S., Ohashi, N., Goto, D. et al. A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation. CEN Case Rep 10, 476–482 (2021). https://doi.org/10.1007/s13730-021-00592-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-021-00592-z